Your browser doesn't support javascript.
loading
Acute ketosis inhibits appetite and decreases plasma concentrations of acyl ghrelin in healthy young men.
Vestergaard, Esben Thyssen; Zubanovic, Natasa Brkovic; Rittig, Nikolaj; Møller, Niels; Kuhre, Rune Ehrenreich; Holst, Jens J; Rehfeld, Jens F; Thomsen, Henrik Holm.
Afiliação
  • Vestergaard ET; Department of Paediatrics, Regional Hospital Randers, Randers, Denmark.
  • Zubanovic NB; Steno Diabetes Center Aarhus (SDCA), Aarhus, Denmark.
  • Rittig N; Department of Internal Medicine, Clinic for Diabetes and Endocrinology, Viborg Regional Hospital, Viborg, Denmark.
  • Møller N; Department and Laboratory of Internal Medicine and Endocrinology, MEA, Aarhus University Hospital, Aarhus, Denmark.
  • Kuhre RE; Steno Diabetes Center Aarhus (SDCA), Aarhus, Denmark.
  • Holst JJ; Department and Laboratory of Internal Medicine and Endocrinology, MEA, Aarhus University Hospital, Aarhus, Denmark.
  • Rehfeld JF; Department and Laboratory of Internal Medicine and Endocrinology, MEA, Aarhus University Hospital, Aarhus, Denmark.
  • Thomsen HH; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Diabetes Obes Metab ; 23(8): 1834-1842, 2021 08.
Article em En | MEDLINE | ID: mdl-33852195
AIM: To investigate the acute effect of ketone ester (KE) ingestion on appetite and plasma concentrations of acyl ghrelin (AG), unacylated ghrelin (UAG) and glucagon-like peptide-1 (GLP-1) secretion, and to compare responses with those elicited by isocaloric glucose (GLU) administration. METHODS: We examined 10 healthy young men on three separate occasions using a placebo (PBO)-controlled crossover design. A KE versus taste-matched isovolumetric and isocaloric 50% GLU and taste-matched isovolumetric PBO vehicle was orally administered. Our main outcome measures were plasma concentrations of AG, UAG, glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 along with appetite sensation scores assessed by visual analogue scale. RESULTS: KE ingestion resulted in an average peak beta-hydroxybutyrate concentration of 5.5 mM. AG and UAG were lowered by approximately 25% following both KE and GLU intake compared with PBO. In the case of AG, the differences were -52.1 (-79.4, -24.8) for KE and -48.4 (-75.4, -21.5) pg/mL for GLU intake (P < .01). Concentrations of AG remained lower with KE but returned to baseline and were comparable with PBO levels after GLU intake. GLP-1, GIP, gastrin and cholecystokinin were not affected by KE ingestion. CONCLUSION: Our results suggest that the suppressive effects on appetite sensation scores associated with hyperketonaemia are more probable to be mediated through reduced ghrelin concentrations than by increased activity of cholecystokinin, gastrin, GIP or GLP-1.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Grelina / Cetose Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Grelina / Cetose Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca